LECTURE:
“Biological and clinical outcomes in trials”

AND

PANEL DISCUSSION:
“Defining trial success”

Presenters:
Berent Prakken, M.D., Ph.D.,
Professor of Pediatric Immunology
at the University Medical Centre
Utrecht, the Netherlands; Chair, EULAR;

AND

Vicki Seyfert-Margolis, Ph.D.,
Chief Scientific Officer, Immune Tolerance Network

Abstract
Trials, from the pilot stage to phase III, are dependent on outcomes. Outcomes represent the tangible materialization of a researcher’s concept and define the parameters of success. Drs. Vicki Seyfert-Margolis and Berent Prakken will discuss strategies for identifying biological and clinical outcomes in trials at all stages and for defining trial success.

Objectives
1. Identify strategies for identifying biological outcomes
2. Compare effective strategies for identifying clinical outcome
3. Demonstrate how to distinguish strong outcomes from weak or unrealistic ones in defining trial success